Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.
2.
3.

Enhanced activation of T lymphocytes by urease-deficient recombinant bacillus Calmette-Guérin producing heat shock protein 70-major membrane protein-II fusion protein.

Mukai T, Maeda Y, Tamura T, Matsuoka M, Tsukamoto Y, Makino M.

J Immunol. 2010 Nov 15;185(10):6234-43. doi: 10.4049/jimmunol.1000198. Epub 2010 Oct 8.

4.

Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.

Mukai T, Maeda Y, Tamura T, Matsuoka M, Tsukamoto Y, Makino M.

J Immunol. 2009 Nov 15;183(10):6561-8. doi: 10.4049/jimmunol.0803857. Epub 2009 Oct 21.

5.
6.

Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence.

Tsukamoto Y, Maeda Y, Tamura T, Mukai T, Mitarai S, Yamamoto S, Makino M.

Vaccine. 2016 Dec 7;34(50):6301-6308. doi: 10.1016/j.vaccine.2016.10.069. Epub 2016 Nov 12.

PMID:
27847173
7.

[Development of a novel recombinant BCG for tuberculosis vaccine].

Makino M.

Nihon Hansenbyo Gakkai Zasshi. 2013 Dec;82(3):107-10. Review. Japanese.

PMID:
24579457
8.

Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosis.

Tsukamoto Y, Endoh M, Mukai T, Maeda Y, Tamura T, Kai M, Makino M.

Clin Vaccine Immunol. 2011 Feb;18(2):235-42. doi: 10.1128/CVI.00459-10. Epub 2010 Dec 15.

9.

CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin.

Mukai T, Maeda Y, Tamura T, Miyamoto Y, Makino M.

FEMS Immunol Med Microbiol. 2008 Jun;53(1):96-106. doi: 10.1111/j.1574-695X.2008.00407.x. Epub 2008 Apr 8.

12.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

13.

Critical role of TRIF and MyD88 in Mycobacterium tuberculosis Hsp70-mediated activation of dendritic cells.

Kim TH, Shin SJ, Park YM, Jung ID, Ryu SW, Kim DJ, Park JH, Park JH.

Cytokine. 2015 Feb;71(2):139-44. doi: 10.1016/j.cyto.2014.09.010. Epub 2014 Oct 29.

PMID:
25461391
15.

The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.

Satchidanandam V, Kumar N, Jumani RS, Challu V, Elangovan S, Khan NA.

PLoS Pathog. 2014 Jun 12;10(6):e1004176. doi: 10.1371/journal.ppat.1004176. eCollection 2014 Jun. Erratum in: PLoS Pathog. 2014 Aug;10(8):e1004352.

16.

A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.

Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.

Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x. Epub 2015 Sep 12.

PMID:
26363555
17.
18.
19.

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.

Xu ZZ, Chen X, Hu T, Meng C, Wang XB, Rao Y, Zhang XM, Yin YL, Pan ZM, Jiao XA.

Front Cell Infect Microbiol. 2016 Jan 28;6:3. doi: 10.3389/fcimb.2016.00003. eCollection 2016.

Supplemental Content

Support Center